Comparative Bioavailability Study of Metformin/Sitagliptin 850 mg/50 mg Tablets in Healthy Male and Female Volunteers
Status:
Completed
Trial end date:
2017-11-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to evaluate and compare the bioavailability and therefore to
assess the bioequivalence of two different formulations of metformin/sitagliptin after a
single oral dose administration under fed conditions.